What if the kind of cuts we should be talking about are the ones that actually make care better? Like cutting confusion. Because for many people, the biggest barrier to healthcare access isn’t cost or availability – it’s complexity. The post A Call for Healthcare Cuts — But Not the Kind You’re Thinking Of appeared…
“We spend a lot of time focused on building the experiences that we think are the future of healthcare, and we don’t spend a heck of a lot of time worrying about what other people are doing,” declares Dan Caron, founder and CEO of Health Universe. Here’s a Q&A with the leader of the Kleiner…
Some hospitals are turning to AI to help manage declining revenue and financial pressure, but one expert says success depends on more than just buying new tech. Prashant Karamchandani of Chartis urged health systems to pair AI adoption with foundational work like change management, continuous improvement and operating model redesign. The post Why Hospitals Must…
President Donald Trump earlier this year bought as much as $680,000 in stock of Eli Lilly, the maker of blockbuster obesity drugs, as the agencies he oversees undertook an agenda that largely benefited the company. On May 14, the federal government released ethics disclosures revealing a list of stock and bond trades made on Trump’s…
Waiv, formerly the diagnostics division of AI biotech Owkin, developed AI-enabled testing technologies that found use in clinical settings and in cancer drug research. Spinning out as an independent company enables Waiv to pursue its own growth strategy, co-founder and CEO Meriem Sefta said. The post Startup Waiv Spins Out of Owkin With $33M to…
The current Affordable Care Act open enrollment season is the first big test of new federal guardrails against fraud. The rules aim to head off unauthorized ACA plan enrollments or switches by rogue agents and entities looking to make money via enrollment commissions. Such sign-ups triggered more than 274,000 consumer complaints through August this year….
Alumis’s genomic research guided its development of envudeucitinib, a TYK2 inhibitor that some analysts now view as best in class. The Phase 3 results that will support a planned FDA submission in plaque psoriasis are scheduled for presentation this weekend during the American Academy of Dermatology annual meeting in Denver. The post Taking a Page…
Jonah, de 8 años, se despertó una mañana de mayo con la cara hinchada y dolor de muelas. Se negó a tomar el medicamento para el dolor que su mamá, Geneva Reynolds, trató de darle. No dormía ni comía y lloraba sin parar. En pocos días, Reynolds estaba tan desesperada que ella y su esposo…
[Sponsored] California’s leading facial plastic surgeons redefine revision facelifts through precision, innovation and patient-centered artistry. Find out which ones get the best results. The post California’s Top Revision Facelift Surgeons: Achieving Optimal Results appeared first on MedCity News.
The 2026 Medicare ACO landscape features expanded participation, new models like LEAD, and a focus on advanced payment tracks